Cargando…
Mutant Proteomics of Lung Adenocarcinomas Harboring Different EGFR Mutations
Epidermal growth factor receptor EGFR major driver mutations may affect downstream molecular networks and pathways, which would influence treatment outcomes of non-small cell lung cancer (NSCLC). This study aimed to unveil profiles of mutant proteins expressed in lung adenocarcinomas of 36 patients...
Autores principales: | Nishimura, Toshihide, Végvári, Ákos, Nakamura, Haruhiko, Kato, Harubumi, Saji, Hisashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477350/ https://www.ncbi.nlm.nih.gov/pubmed/32983988 http://dx.doi.org/10.3389/fonc.2020.01494 |
Ejemplares similares
-
Disease-related cellular protein networks differentially affected under different EGFR mutations in lung adenocarcinoma
por: Nishimura, Toshihide, et al.
Publicado: (2020) -
Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases
por: Shi, Liang, et al.
Publicado: (2021) -
A proteogenomic profile of early lung adenocarcinomas by protein co-expression network and genomic alteration analysis
por: Nishimura, Toshihide, et al.
Publicado: (2020) -
A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types
por: Kato, Yasufumi, et al.
Publicado: (2015) -
Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation
por: Bruno, Rossella, et al.
Publicado: (2021)